Understanding Stiripentol Induced Hepatotoxicity

Stiripentol (STP) is an effective antiepileptic medication often prescribed for Dravet syndrome. While clinicians value its efficacy, documented cases of liver injury raise significant concerns. Recent research provides a new perspective by linking Stiripentol induced hepatotoxicity to the formation of reactive metabolites and subsequent protein adduction. Researchers suggest that STP metabolism generates an electrophilic carbonium ion. This reactive intermediate then forms hepatic glutathione (GSH) conjugates and binds to essential proteins, causing cellular damage.

The Metabolic Pathway of Liver Injury

The study identifies two distinct pathways for carbonium ion production. First, the drug can undergo spontaneous dehydration. Second, sulfation catalyzed by sulfotransferases (SULTs) significantly accelerates this process. Furthermore, experiments using mouse liver cytosol showed that adding sulfation cofactors increased the production of reactive metabolites. Consequently, inhibiting SULTs with 2,6-dichloro-4-nitrophenol successfully reduced protein adduction levels. These findings confirm that metabolic activation is a primary driver of Stiripentol induced hepatotoxicity.

Protective Role of Glutathione

Glutathione (GSH) acts as a critical defense against metabolic toxicity. In mouse models, protein adduction and serum liver enzyme activities showed clear dose-dependent trends. Moreover, when researchers co-treated hepatocytes with L-Buthionine-sulfoximine to deplete GSH, they observed a sharp increase in susceptibility to cytotoxicity. This evidence highlights that GSH serves a vital detoxification function. Therefore, maintaining adequate glutathione levels may be essential for patients undergoing long-term therapy to prevent Stiripentol induced hepatotoxicity.

FAQs about Stiripentol and Liver Safety

What is the main cause of Stiripentol induced hepatotoxicity?

Research indicates that the production of electrophilic carbonium ions leads to protein adduction in the liver, which causes cellular injury and elevated liver enzymes.

How do sulfotransferases (SULTs) affect Stiripentol metabolism?

SULTs catalyze the sulfation of Stiripentol, which accelerates the formation of reactive carbonium ions. These ions are responsible for hepatic protein binding and toxicity.

Can glutathione protect the liver from Stiripentol damage?

Yes, glutathione serves a detoxification role by conjugating with reactive metabolites before they can bind to and damage hepatic proteins.

Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or a professional relationship. Always consult a healthcare professional for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.

References

Lin Y et al. Protein Adduction and Hepatotoxicity Induced by Stiripentol. Chem Res Toxicol. 2026 Apr 28. doi: 10.1021/acs.chemrestox.6c00109. PMID: 42047167.

LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012-. Stiripentol. [Updated 2020 Jun 4].

European Medicines Agency (EMA). Diacomit (Stiripentol): Summary of Product Characteristics.